Articles from Fogarty Innovation

Allan Zingeler, Raju Viswanathan, PhD, and Michael Mahoney of Boston Scientific have been awarded the inaugural Thomas J. Fogarty Prize (Fogarty Prize) for the FARAPULSE™ PFA Platform. The award, which includes an unrestricted $100,000 cash prize and a custom-cast bronze medallion, was announced on October 24 at a sold-out black-tie gala in San Francisco. More than 300 leaders from medtech, venture, academia, healthcare, and local government attended the celebration. The Fogarty Prize honors innovators who have developed and successfully commercialized a life-changing medical technology.

Therapies that have transformed the treatment of cancer, atrial fibrillation, and life-threatening birth defects have been named finalists for the inaugural Thomas J. Fogarty Innovation Prize (Fogarty Prize). This prestigious new recognition honors an innovator or team who has developed and successfully commercialized a life-changing medical technology. The finalists will be celebrated, and the winner announced, at a black-tie gala in San Francisco on October 24. The winning individual or team will receive an unrestricted $100,000 cash prize and a custom-cast bronze medal.

Nominations open next week for the inaugural “Thomas J. Fogarty Prize” (Fogarty Prize), a prestigious new recognition for an innovator or team who has developed and brought to market a lifechanging medical technology. The award consists of an unrestricted $100,000 cash prize, a custom-cast bronze medal, and a formal celebratory dinner and award ceremony with medtech leaders in Silicon Valley.